688488 艾迪药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-5.553-6.545-9.893-2.2464.151
总资产报酬率 ROA (%)-3.317-4.472-8.032-2.0813.570
投入资产回报率 ROIC (%)-3.881-5.052-8.871-2.1983.815

边际利润分析
销售毛利率 (%)52.81146.19542.90133.19150.092
营业利润率 (%)-25.874-22.376-58.175-17.14317.142
息税前利润/营业总收入 (%)-23.072-19.843-58.139-17.37516.860
净利润/营业总收入 (%)-20.652-18.492-50.812-11.72613.759

收益指标分析
经营活动净收益/利润总额(%)101.75596.92891.603123.45466.793
价值变动净收益/利润总额(%)-39.378-15.376-11.805-19.1426.451
营业外收支净额/利润总额(%)1.4870.0400.218-3.697-5.013

偿债能力分析
流动比率 (X)1.5071.7752.4198.93613.790
速动比率 (X)1.1131.3991.9497.70112.584
资产负债率 (%)40.22635.55727.5788.7006.011
带息债务/全部投入资本 (%)28.61623.71913.326-0.1871.119
股东权益/带息债务 (%)235.491305.446617.002-52,227.9978,743.116
股东权益/负债合计 (%)137.854181.238262.6081,049.3751,563.592
利息保障倍数 (X)-7.225-7.805-356.43520.61231.411

营运能力分析
应收账款周转天数 (天)149.500129.628126.837126.673170.121
存货周转天数 (天)411.123277.339349.064213.182191.791